Pfizer in talks to buy cancer drugmaker Seagen - WSJ

日本 ニュース ニュース

Pfizer in talks to buy cancer drugmaker Seagen - WSJ
日本 最新ニュース,日本 見出し
  • 📰 Reuters
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

Pfizer Inc is in early-stage talks to acquire cancer drugmaker Seagen Inc in what could be a multi-billion dollar deal, the Wall Street Journal reported on Sunday, citing people familiar with the matter.

Seagen had a market capitalization of roughly $30 billion, as of Friday's close., in a deal that would have been worth $40 billion or more, the Journal reported last year, but the two sides failed to reach an agreement, according to multiple reports.

Seagen's shares have fallen nearly 10% since July, when the deal talks with Merck were first reported. They rose 12.3% to $182 in premarket trading on Monday. Pfizer declined to comment on the WSJ report, while Seagen did not immediately respond to a Reuters request for comment.it expects to lose $17 billion in annual sales between 2025 and 2030 due to patent expirations for top drugs, and sales of its COVID-19 products have begun to decline after they contributed to an unprecedented surge in revenue.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

Reuters /  🏆 2. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Pfizer in talks to buy Seagen for likely for more than $30 bln - WSJPfizer in talks to buy Seagen for likely for more than $30 bln - WSJPfizer Inc is in early talks to acquire drugmaker Seagen Inc , the Wall Street Journal reported late on Sunday, citing people familiar with the matter.
続きを読む »

Pfizer eyes takeover of biotech Seagen, at value of more than $30 billionPfizer eyes takeover of biotech Seagen, at value of more than $30 billionPfizer Inc. is in talks to acquire biotech Seagen Inc., according to people familiar with the matter, the latest potential deal for a big drug company aimed...
続きを読む »

WSJ News Exclusive | Pfizer in Talks to Acquire Seagen in Deal Likely Valued at More Than $30 BillionBreaking: Pfizer is in early-stage talks to acquire biotech Seagen, valued at about $30 billion, and its pioneering targeted cancer therapies
続きを読む »

Merck's Big Upgrade: 4 Big Analyst Calls | Pro Recap | Investing.comMerck's Big Upgrade: 4 Big Analyst Calls | Pro Recap | Investing.comStocks Analysis by Garrett Cook covering: Alcoa Corp, Merck & Company Inc, Wingstop Inc, Dun And Bradstreet Holding Inc. Read Garrett Cook's latest article on Investing.com
続きを読む »

Streaming Confusion: WSJ Readers Struggle to Make Sense of It AllStreaming Confusion: WSJ Readers Struggle to Make Sense of It AllWe asked Wall Street Journal readers how they're juggling streaming services, or whether they’ve found a simpler way to just watch TV
続きを読む »

WSJ News Exclusive | Lab Leak Most Likely Origin of Covid-19 Pandemic, Energy Department Now SaysWSJ News Exclusive | Lab Leak Most Likely Origin of Covid-19 Pandemic, Energy Department Now SaysThe Energy Department joins the FBI in saying the virus likely spread via a mishap at a Chinese laboratory. Four other agencies, along with a national intelligence panel, still judge that it was likely the result of a natural transmission, and two are undecided.
続きを読む »



Render Time: 2025-03-05 23:14:52